SCARA5
Basic information
Region (hg38): 8:27869883-27992673
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCARA5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 40 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 1 | 0 |
Variants in SCARA5
This is a list of pathogenic ClinVar variants found in the SCARA5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-27872011-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
8-27872050-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
8-27879695-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
8-27879718-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
8-27879749-T-C | not specified | Uncertain significance (May 06, 2024) | ||
8-27879751-G-A | not specified | Uncertain significance (Jun 22, 2024) | ||
8-27904784-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
8-27907162-A-C | not specified | Uncertain significance (Feb 17, 2023) | ||
8-27907196-C-T | not specified | Uncertain significance (Nov 18, 2023) | ||
8-27907235-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
8-27907238-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
8-27909737-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
8-27921657-A-G | not specified | Uncertain significance (Apr 12, 2023) | ||
8-27921688-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
8-27921699-C-G | not specified | Uncertain significance (Mar 07, 2024) | ||
8-27921709-G-A | not specified | Uncertain significance (May 31, 2023) | ||
8-27921715-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
8-27921741-C-T | not specified | Likely benign (Feb 01, 2023) | ||
8-27921813-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
8-27921868-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
8-27921885-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
8-27921920-C-A | not specified | Uncertain significance (Feb 05, 2024) | ||
8-27921921-T-C | not specified | Uncertain significance (Jan 29, 2024) | ||
8-27921934-G-T | not specified | Uncertain significance (Mar 18, 2024) | ||
8-27921969-C-T | not specified | Uncertain significance (Jan 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SCARA5 | protein_coding | protein_coding | ENST00000354914 | 8 | 122846 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000104 | 0.945 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.382 | 287 | 306 | 0.939 | 0.0000214 | 3122 |
Missense in Polyphen | 84 | 97.454 | 0.86194 | 989 | ||
Synonymous | 1.67 | 115 | 140 | 0.820 | 0.0000106 | 1036 |
Loss of Function | 1.79 | 11 | 19.5 | 0.563 | 0.00000104 | 216 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000186 | 0.000182 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000171 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000106 | 0.0000967 |
Middle Eastern | 0.000171 | 0.000163 |
South Asian | 0.0000679 | 0.0000653 |
Other | 0.000178 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Ferritin receptor that mediates non-transferrin- dependent delivery of iron. Mediates cellular uptake of ferritin- bound iron by stimulating ferritin endocytosis from the cell surface with consequent iron delivery within the cell. Delivery of iron to cells by ferritin is required for the development of specific cell types, suggesting the existence of cell type- specific mechanisms of iron traffic in organogenesis, which alternatively utilize transferrin or non-transferrin iron delivery pathways. Ferritin mediates iron uptake in capsule cells of the developing kidney. Binds preferrentially ferritin light chain (FTL) compared to heavy chain (FTH1). {ECO:0000255|HAMAP- Rule:MF_03070}.;
- Pathway
- Vesicle-mediated transport;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.162
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.42
Haploinsufficiency Scores
- pHI
- 0.184
- hipred
- N
- hipred_score
- 0.417
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.544
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Scara5
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; immune system phenotype; renal/urinary system phenotype; liver/biliary system phenotype; respiratory system phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- cellular iron ion homeostasis;endocytosis;receptor-mediated endocytosis;cellular response to heat;iron ion transmembrane transport;protein homotrimerization
- Cellular component
- integral component of plasma membrane;cell surface
- Molecular function
- scavenger receptor activity;ferritin receptor activity